Import safety summit
This article was originally published in The Tan Sheet
Executive Summary
FDA Commissioner Andrew von Eschenbach will moderate a discussion on the legal and regulatory safety and security requirements for the drug industry at the Import Safety Summit July 9 in Washington, the Consumer Healthcare Products Association announces. The summit, cosponsored by CHPA and other trade and advocacy groups, will include a keynote address by Health and Human Services Secretary Michael Leavitt and sessions on import safety challenges, standard-setting, auditing and certification efforts in an evolving global marketplace...You may also be interested in...
QUOTED. 19 February 2020. Stephen Hahn.
The US FDA has abandoned all near-term plans to inspect Chinese manufacturing facilities in the wake of the coronavirus crisis. See what agency head Stephen Hahn said about it here.
DevaCurl Faces Multiple Class Actions As Latest Brand Linked To Hair Loss
The company maintains that its products are safe, but plaintiffs in proposed class actions allege it has knowingly put consumers at risk of hair loss and other injuries. DevaCurl’s troubles escalated quickly after a former brand ambassador went viral with a 31 January video urging consumers to stop using DevaCurl products and adopt safer alternatives.
Could ICER Outreach To US FDA Lead To Better Cost Effectiveness Analyses?
To aid its value assessments, ICER is interested in helping FDA understand the importance of patient-relevant outcomes and consistent endpoints across trials of drugs for the same disease.
Need a specific report? 1000+ reports available
Buy Reports
Register for our free email digests: